Dr. Reddy's Lab launches Lansoprazole Delayed-Release Capsules in US market

16 Sep 2019 Evaluate

Dr. Reddy's Laboratories has launched Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter (OTC) store-brand equivalent of Prevacid 24HR Capsules, in the United States market, as approved by the US Food and Drug Administration (USFDA).

Dr. Reddy's OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn occurring two or more days a week.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1199.10 -25.20 (-2.06%)
29-Jan-2026 13:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1597.00
Dr. Reddys Lab 1199.10
Cipla 1316.90
Zydus Lifesciences 886.85
Lupin 2122.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×